Phenotypic changes in acute myeloid leukaemia: Implications in the detection of minimal residual disease

Journal of Clinical Pathology

Volumn 49, Issue 1, 1996, Pages 15-18

  Macedo, A ^a   San Miguel, J F ^a   Vidriales, M B ^a   Lopez Berges M C ^a   Garcia Marcos M A ^a   Gonzalez, M ^a   Landolfi, C ^a   Orfao A ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

AML; Minimal residual disease; Phenotypic changes; Relapse

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR MARKER;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0030024373     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.1.15     Document Type: Article

References (20)

1. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al. Report of the National Cancer Institute sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813-9.
2. Stass S, Mirro J, Melvin S, Pui CH, Murphy SB, Williams D. Lineage switch in acute leukemia. Blood 1984;64: 701-8.
3. Wörman B, Griesinger F, Innig G, Kolkmeyer A, Toepken S, Grove D, et al. Detection of residual leukaemic cells in patients with acute myeloid leukemia based on cell surface antigen expression. Sangre 1992;37:133-5.
4. Campana D, Coustan-Smith E, Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990;76:163-71.
5. Van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992;6(suppl 1): 47-59.
6. Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, Van Dongen JJM. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers. Leukemia 1993;7:472-81.
7. Coustan-Smith E, Behm FG, Hurwitz CA, Rivera GK, Campana D. N-Cam (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993;7:853-8.
8. Terstappen LWMM, Safford M, Konemann S, Loken MR, Zurlutter K, Buchner T, et al. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991;5:757-67.
9. Pui CH, Raimondi SC, Behm FG, Ochs J, Furman WL, Bunin NJ, et al. Skills in blast cell phenotype and caryotype at relapse of childhood lymphoblastic leukemia. Blood 1986;68:1306-10.
10. Drach J, Drach D, Glassl H, Gattringer C, Huber H. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry 1992;13:893-901.
11. Greaves MF. Target cells, cellular phenotype and lineage fidelity in human leukemia. J Cell Physiol 1982;suppl 1: 113-26.
12. Ruiz-Arguelles GJ, Lobato-Mendizábal E, Marín-López A. The incidence of hybrid acute leukaemia. Leukemia Res 1988;12:707-9.
13. Drexler HG, Scott CS. Morphological and immunological aspects of leukaemia diagnosis. In: Scott CS, ed. Leukaemia cytochemistry principles and practice. Chichester: Ellis Horwood, 1989:13-59.
14. Gómez H, San Miguel JF, González M, Orfão A, Cañizo MC, Ciudad J, et al. Cambios fenotipicos de las leucernias agudas linfoblásticas en recaida y resistentes. Sangre 1991; 36:201-4.
15. Reichle A, Volkman M, Pachmann K, Diddens H, Emmerich B, Rastetter J. Changes in clonal growth, immunophenotype and morphology during a follow-up study of an acute lymphoblastic leukemia. In: Buchner, Schellong, Hiddeman, Ritter, eds. Haematology and blood transfusion, vol 33. Heidelberg: Springer, 1990:159-65.
16. Borella L, Casper JT, Lauer SJ. Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse. Blood 1979;54:64-70.
17. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 1968;32: 507-23.
18. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of acute leukemias. A report of the French-American-British Cooperative Group. Br J Haematol 1976;33:451-8.
19. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, et al. (FAB group): Proposed revised criteria for the classification of AML. Ann Intern Med 1985;103:626-9.
20. Terstappen LWMM, Mickaels RA, Dost R, Loken MR. Increased light scattering resolution facilitates multidimensional flow cytometrics analysis. Cytometry 1990;11: 506-12.